| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.766 | 0.021 | 0.856 | Apoptosis agonist | 0.75 0.023 DBMET03367 0.728 0.026 DBMET03365 0.723 0.027 DBMET03366 0.856 0.01 DB12148 0.711 0.029 DBMET03368 | DB12148 | |
| 0.695 | 0.006 | 0.79 | Antioxidant | 0.674 0.007 DBMET03367 0.667 0.007 DBMET03365 0.676 0.007 DBMET03366 0.79 0.004 DB12148 0.657 0.008 DBMET03368 | DB12148 | |
| 0.685 | 0.005 | 0.787 | Histamine release inhibitor | 0.665 0.006 DBMET03367 0.619 0.009 DBMET03365 0.787 0.004 DBMET03366 0.679 0.005 DB12148 0.684 0.005 DBMET03368 | DBMET03366 | |
| 0.695 | 0.032 | 0.808 | Antiinflammatory | 0.651 0.041 DBMET03367 0.758 0.021 DBMET03365 0.743 0.023 DBMET03366 0.808 0.014 DB12148 0.736 0.024 DBMET03368 | DB12148 | |
| 0.6 | 0.004 | 0.667 | Lipid peroxidase inhibitor | 0.528 0.005 DBMET03367 0.511 0.005 DBMET03365 0.563 0.004 DBMET03366 0.667 0.003 DB12148 0.533 0.005 DBMET03368 | DB12148 | |
| 0.624 | 0.028 | 0.666 | Transcription factor NF kappa B inhibitor | 0.624 0.028 DBMET03367 0.645 0.026 DBMET03365 0.623 0.029 DBMET03366 0.666 0.024 DB12148 0.644 0.026 DBMET03368 | DB12148 | |
| 0.601 | 0.013 | 0.605 | Immunosuppressant | 0.605 0.013 DBMET03367 0.501 0.033 DBMET03365 0.574 0.017 DBMET03366 0.572 0.017 DB12148 0.604 0.013 DBMET03368 | DBMET03367 | |
| 0.566 | 0.003 | 0.592 | Electron transport complex I inhibitor | 0.524 0.003 DBMET03367 0.452 0.004 DBMET03365 0.524 0.003 DBMET03366 0.592 0.002 DB12148 0.518 0.003 DBMET03368 | DB12148 | |
| 0.563 | 0.012 | 0.714 | Lipoxygenase inhibitor | 0.479 0.022 DBMET03367 0.623 0.008 DBMET03365 0.697 0.005 DBMET03366 0.714 0.005 DB12148 0.65 0.007 DBMET03368 | DB12148 | |
| 0.567 | 0.025 | 0.588 | Antibacterial | 0.55 0.028 DBMET03367 0.519 0.035 DBMET03365 0.53 0.033 DBMET03366 0.561 0.026 DB12148 0.588 0.021 DBMET03368 | DBMET03368 | |
| 0.533 | 0.01 | 0.638 | Hypolipemic | 0.496 0.013 DBMET03367 0.358 0.033 DBMET03365 0.496 0.013 DBMET03366 0.565 0.008 DB12148 0.638 0.005 DBMET03368 | DBMET03368 | |
| 0.529 | 0.013 | 0.614 | Free radical scavenger | 0.522 0.014 DBMET03367 0.571 0.01 DBMET03365 0.558 0.011 DBMET03366 0.614 0.008 DB12148 0.487 0.017 DBMET03368 | DB12148 | |
| 0.538 | 0.033 | 0.696 | 15-Lipoxygenase inhibitor | 0.414 0.068 DBMET03367 0.511 0.038 DBMET03365 0.541 0.033 DBMET03366 0.696 0.013 DB12148 0.42 0.066 DBMET03368 | DB12148 | |
| 0.509 | 0.019 | 0.595 | Apoptosis antagonist | 0.417 0.034 DBMET03367 0.581 0.012 DBMET03365 0.595 0.01 DBMET03366 0.591 0.01 DB12148 0.526 0.017 DBMET03368 | DBMET03366 | |
| 0.531 | 0.049 | 0.791 | Caspase 9 stimulant | 0.48 0.068 DBMET03367 0.69 0.025 DBMET03365 0.744 0.019 DBMET03366 0.791 0.012 DB12148 0.472 0.072 DBMET03368 | DB12148 | |
| 0.469 | 0.005 | 0.469 | Hemostatic | 0.401 0.008 DBMET03367 0.365 0.01 DBMET03365 0.459 0.005 DBMET03366 0.413 0.007 DB12148 0.411 0.007 DBMET03368 | ||
| 0.489 | 0.024 | 0.549 | Spasmolytic | 0.444 0.032 DBMET03367 0.409 0.038 DBMET03365 0.512 0.021 DBMET03366 0.549 0.018 DB12148 0.528 0.02 DBMET03368 | DB12148 | |
| 0.479 | 0.023 | 0.68 | Caspase 3 stimulant | 0.401 0.044 DBMET03367 0.587 0.011 DBMET03365 0.522 0.017 DBMET03366 0.68 0.006 DB12148 0.404 0.043 DBMET03368 | DB12148 | |
| 0.472 | 0.033 | 0.598 | Antithrombotic | 0.557 0.021 DBMET03367 0.466 0.034 DBMET03365 0.598 0.016 DBMET03366 0.514 0.027 DB12148 0.593 0.017 DBMET03368 | DBMET03366 | |
| 0.436 | 0.01 | 0.441 | Melanin inhibitor | 0.415 0.011 DBMET03367 0.319 0.02 DBMET03365 0.385 0.013 DBMET03366 0.441 0.009 DB12148 0.42 0.01 DBMET03368 | DB12148 | |
| 0.385 | 0.005 | 0.427 | Cholesterol synthesis inhibitor | 0.371 0.005 DBMET03367 0.339 0.008 DBMET03365 0.352 0.007 DBMET03366 0.344 0.007 DB12148 0.427 0.004 DBMET03368 | DBMET03368 | |
| 0.36 | 0.003 | 0.526 | Papain-like protease (SARS coronavirus) inhibitor | 0.299 0.004 DBMET03367 0.275 0.004 DBMET03365 0.362 0.003 DBMET03366 0.526 0.002 DB12148 0.302 0.004 DBMET03368 | DB12148 | |
| 0.357 | 0.007 | 0.492 | 5-Lipoxygenase inhibitor | 0.278 0.013 DBMET03367 0.404 0.005 DBMET03365 0.401 0.005 DBMET03366 0.492 0.004 DB12148 0.34 0.008 DBMET03368 | DB12148 | |
| 0.399 | 0.05 | 0.422 | Immunostimulant | 0.389 0.053 DBMET03367 0.287 0.082 DBMET03365 0.403 0.048 DBMET03366 0.353 0.063 DB12148 0.422 0.044 DBMET03368 | DBMET03368 | |
| 0.373 | 0.029 | 0.505 | Nitric oxide antagonist | 0.339 0.033 DBMET03367 0.436 0.021 DBMET03365 0.387 0.027 DBMET03366 0.505 0.015 DB12148 0.386 0.027 DBMET03368 | DB12148 | |
| 0.355 | 0.012 | 0.444 | Protein-tyrosine phosphatase inhibitor | 0.346 0.013 DBMET03367 0.444 0.006 DBMET03365 0.423 0.007 DBMET03366 0.443 0.006 DB12148 0.368 0.011 DBMET03368 | DBMET03365 | |
| 0.336 | 0.015 | 0.344 | Gastrin inhibitor | 0.298 0.035 DBMET03367 0.247 0.083 DBMET03365 0.344 0.012 DBMET03366 0.326 0.018 DB12148 0.327 0.018 DBMET03368 | DBMET03366 | |
| 0.328 | 0.014 | 0.328 | Bone formation stimulant | 0.297 0.017 DBMET03367 0.23 0.029 DBMET03365 0.328 0.014 DBMET03366 0.312 0.016 DB12148 0.315 0.015 DBMET03368 | ||
| 0.32 | 0.009 | 0.413 | Protein-tyrosine phosphatase 1B inhibitor | 0.312 0.01 DBMET03367 0.404 0.005 DBMET03365 0.372 0.006 DBMET03366 0.413 0.005 DB12148 0.329 0.009 DBMET03368 | DB12148 | |
| 0.306 | 0.004 | 0.306 | CDC25A inhibitor | 0.245 0.004 DBMET03367 0.209 0.006 DBMET03365 0.241 0.004 DBMET03366 0.267 0.004 DB12148 0.269 0.004 DBMET03368 | ||
| 0.354 | 0.056 | 0.358 | 5 Hydroxytryptamine release stimulant | 0.223 0.104 DBMET03367 0.358 0.055 DBMET03365 0.185 0.135 DBMET03366 0.205 0.117 DB12148 0.213 0.111 DBMET03368 | DBMET03365 | |
| 0.302 | 0.007 | 0.459 | Antibacterial (Helicobacter pylori) | 0.238 0.014 DBMET03367 0.187 0.026 DBMET03365 0.321 0.006 DBMET03366 0.459 0.004 DB12148 0.28 0.009 DBMET03368 | DB12148 | |
| 0.335 | 0.04 | 0.41 | Superoxide dismutase inhibitor | 0.315 0.046 DBMET03367 0.41 0.025 DBMET03365 0.404 0.026 DBMET03366 0.342 0.038 DB12148 0.33 0.041 DBMET03368 | DBMET03365 | |
| 0.329 | 0.039 | 0.422 | Vasodilator | 0.275 0.057 DBMET03367 0.31 0.045 DBMET03365 0.369 0.029 DBMET03366 0.422 0.02 DB12148 0.349 0.033 DBMET03368 | DB12148 | |
| 0.3 | 0.018 | 0.3 | NOS3 expression enhancer | 0.22 0.034 DBMET03367 0.276 0.022 DBMET03365 0.258 0.025 DBMET03366 0.281 0.021 DB12148 0.243 0.028 DBMET03368 | ||
| 0.307 | 0.028 | 0.371 | Hepatoprotectant | 0.298 0.03 DBMET03367 0.371 0.016 DBMET03365 0.331 0.022 DBMET03366 0.341 0.02 DB12148 0.352 0.019 DBMET03368 | DBMET03365 | |
| 0.294 | 0.014 | 0.404 | Phospholipase A2 inhibitor | 0.291 0.015 DBMET03367 0.342 0.009 DBMET03365 0.404 0.005 DBMET03366 0.312 0.012 DB12148 0.367 0.006 DBMET03368 | DBMET03366 | |
| 0.285 | 0.008 | 0.469 | Mediator release inhibitor | 0.245 0.01 DBMET03367 0.274 0.008 DBMET03365 0.469 0.004 DBMET03366 0.385 0.005 DB12148 0.259 0.009 DBMET03368 | DBMET03366 | |
| 0.341 | 0.068 | 0.541 | Cholesterol antagonist | 0.34 0.068 DBMET03367 0.541 0.026 DBMET03365 0.519 0.03 DBMET03366 0.354 0.062 DB12148 0.37 0.057 DBMET03368 | DBMET03365 | |
| 0.293 | 0.02 | 0.48 | Neurotrophic factor enhancer | 0.288 0.022 DBMET03367 0.282 0.023 DBMET03365 0.357 0.008 DBMET03366 0.48 0.004 DB12148 0.284 0.023 DBMET03368 | DB12148 | |
| 0.313 | 0.049 | 0.504 | Hypoglycemic | 0.427 0.023 DBMET03367 0.502 0.015 DBMET03365 0.504 0.015 DBMET03366 0.448 0.021 DB12148 0.435 0.022 DBMET03368 | DBMET03366 | |
| 0.309 | 0.049 | 0.309 | Transcription factor STAT3 inhibitor | 0.224 0.107 DBMET03367 0.25 0.083 DBMET03365 0.2 0.134 DBMET03366 0.26 0.076 DB12148 0.184 0.158 DBMET03368 | ||
| 0.28 | 0.02 | 0.462 | Monophenol monooxygenase inhibitor | 0.27 0.022 DBMET03367 0.293 0.019 DBMET03365 0.456 0.009 DBMET03366 0.462 0.009 DB12148 0.288 0.019 DBMET03368 | DB12148 | |
| 0.333 | 0.081 | 0.353 | Vasodilator, peripheral | 0.294 0.1 DBMET03367 0.211 0.163 DBMET03365 0.353 0.072 DBMET03366 0.256 0.123 DB12148 0.31 0.092 DBMET03368 | DBMET03366 | |
| 0.254 | 0.014 | 0.255 | Antineoplastic antibiotic | 0.245 0.015 DBMET03367 0.201 0.021 DBMET03365 0.192 0.023 DBMET03366 0.255 0.014 DB12148 0.241 0.015 DBMET03368 | DB12148 | |
| 0.24 | 0.004 | 0.27 | CDC25B inhibitor | 0.164 0.005 DBMET03367 0.27 0.004 DBMET03365 0.17 0.005 DBMET03366 0.222 0.004 DB12148 0.2 0.005 DBMET03368 | DBMET03365 | |
| 0.237 | 0.015 | 0.268 | Neurotrophic factor | 0.201 0.027 DBMET03367 0.115 0.104 DBMET03365 0.19 0.033 DBMET03366 0.268 0.01 DB12148 0.209 0.024 DBMET03368 | DB12148 | |
| 0.232 | 0.011 | 0.254 | Arachidonic acid antagonist | 0.237 0.009 DBMET03367 0.228 0.013 DBMET03365 0.254 0.005 DBMET03366 0.249 0.005 DB12148 0.238 0.009 DBMET03368 | DBMET03366 | |
| 0.254 | 0.037 | 0.282 | Dual specificity phosphatase inhibitor | 0.21 0.05 DBMET03367 0.177 0.069 DBMET03365 0.282 0.031 DBMET03366 0.25 0.038 DB12148 0.279 0.032 DBMET03368 | DBMET03366 | |
| 0.218 | 0.004 | 0.296 | Ca(v)3.1 blocker | 0.155 0.005 DBMET03367 0.142 0.006 DBMET03365 0.161 0.005 DBMET03366 0.296 0.003 DB12148 0.152 0.005 DBMET03368 | DB12148 | |
| 0.259 | 0.045 | 0.272 | Peroxidase inhibitor | 0.206 0.058 DBMET03367 0.272 0.043 DBMET03365 0.161 0.073 DBMET03366 0.236 0.05 DBMET03368 | DBMET03365 | |
| 0.242 | 0.039 | 0.356 | Insulin sensitizer | 0.238 0.042 DBMET03367 0.281 0.021 DBMET03365 0.338 0.01 DBMET03366 0.256 0.031 DB12148 0.356 0.009 DBMET03368 | DBMET03368 | |
| 0.264 | 0.065 | 0.334 | Antiamyloidogenic | 0.334 0.043 DBMET03367 0.186 0.109 DBMET03365 0.183 0.112 DBMET03366 0.152 0.144 DB12148 0.16 0.134 DBMET03368 | DBMET03367 | |
| 0.259 | 0.061 | 0.334 | DNA synthesis inhibitor | 0.267 0.057 DBMET03367 0.333 0.034 DBMET03365 0.334 0.034 DBMET03366 0.22 0.094 DB12148 0.268 0.057 DBMET03368 | DBMET03366 | |
| 0.202 | 0.005 | 0.288 | Lipase inhibitor | 0.151 0.01 DBMET03367 0.189 0.006 DBMET03365 0.188 0.006 DBMET03366 0.288 0.004 DB12148 0.147 0.01 DBMET03368 | DB12148 | |
| 0.264 | 0.069 | 0.264 | Tumour necrosis factor alpha release inhibitor | 0.242 0.078 DBMET03367 0.158 0.149 DB12148 | ||
| 0.328 | 0.136 | 0.35 | 5 Hydroxytryptamine release inhibitor | 0.299 0.166 DBMET03367 0.35 0.115 DBMET03365 0.289 0.178 DBMET03366 0.289 0.178 DBMET03368 | DBMET03365 | |
| 0.259 | 0.069 | 0.504 | Platelet antagonist | 0.357 0.036 DBMET03367 0.323 0.046 DBMET03365 0.463 0.018 DBMET03366 0.219 0.088 DB12148 0.504 0.013 DBMET03368 | DBMET03368 | |
| 0.211 | 0.025 | 0.267 | DNA polymerase I inhibitor | 0.193 0.03 DBMET03367 0.165 0.041 DBMET03365 0.24 0.019 DBMET03366 0.267 0.014 DB12148 0.204 0.027 DBMET03368 | DB12148 | |
| 0.251 | 0.064 | 0.251 | Calpain inhibitor | 0.174 0.143 DBMET03365 | ||
| 0.255 | 0.083 | 0.255 | Transcription factor STAT inhibitor | 0.223 0.109 DBMET03365 0.214 0.119 DB12148 | ||
| 0.194 | 0.024 | 0.261 | Farnesoid X receptor antagonist | 0.175 0.031 DBMET03367 0.174 0.032 DBMET03365 0.21 0.019 DBMET03366 0.261 0.01 DB12148 0.178 0.03 DBMET03368 | DB12148 | |
| 0.204 | 0.04 | 0.296 | Protein kinase stimulant | 0.181 0.049 DBMET03367 0.222 0.034 DBMET03365 0.235 0.03 DBMET03366 0.211 0.038 DB12148 0.296 0.017 DBMET03368 | DBMET03368 | |
| 0.313 | 0.151 | 0.6 | Cyclophilin D inhibitor | 0.46 0.063 DBMET03367 0.586 0.03 DBMET03365 0.6 0.027 DBMET03366 0.486 0.055 DB12148 0.543 0.039 DBMET03368 | DBMET03366 | |
| 0.176 | 0.017 | 0.314 | TRPA1 agonist | 0.132 0.045 DBMET03367 0.145 0.034 DBMET03365 0.215 0.008 DBMET03366 0.314 0.004 DB12148 0.16 0.025 DBMET03368 | DB12148 | |
| 0.198 | 0.042 | 0.264 | Interleukin 6 antagonist | 0.176 0.059 DBMET03367 0.264 0.02 DBMET03365 0.181 0.054 DBMET03366 0.176 0.059 DB12148 0.21 0.036 DBMET03368 | DBMET03365 | |
| 0.165 | 0.009 | 0.235 | Prostaglandin-E synthase inhibitor | 0.097 0.029 DBMET03367 0.217 0.005 DBMET03365 0.186 0.007 DBMET03366 0.235 0.005 DB12148 0.18 0.008 DBMET03368 | DB12148 | |
| 0.199 | 0.045 | 0.298 | Amylase inhibitor | 0.291 0.019 DBMET03367 0.259 0.026 DBMET03365 0.298 0.018 DBMET03366 0.289 0.02 DB12148 0.218 0.038 DBMET03368 | DBMET03366 | |
| 0.153 | 0.004 | 0.163 | Squalene synthetase inhibitor | 0.139 0.004 DBMET03367 0.032 0.023 DBMET03365 0.121 0.005 DBMET03366 0.163 0.003 DB12148 0.152 0.004 DBMET03368 | DB12148 | |
| 0.207 | 0.06 | 0.219 | P-glycoprotein inhibitor | 0.182 0.078 DBMET03367 0.16 0.102 DBMET03365 0.183 0.077 DBMET03366 0.205 0.061 DB12148 0.219 0.053 DBMET03368 | DBMET03368 | |
| 0.17 | 0.023 | 0.17 | Vanilloid 1 agonist | 0.165 0.026 DBMET03367 0.147 0.041 DBMET03365 0.161 0.029 DBMET03366 0.154 0.034 DB12148 0.167 0.025 DBMET03368 | ||
| 0.231 | 0.088 | 0.344 | Tyrosine 3 hydroxylase inhibitor | 0.21 0.119 DBMET03367 0.341 0.018 DBMET03365 0.344 0.017 DBMET03366 0.235 0.084 DB12148 0.265 0.055 DBMET03368 | DBMET03366 | |
| 0.152 | 0.009 | 0.222 | TRPA1 antagonist | 0.222 0.005 DB12148 | DB12148 | |
| 0.232 | 0.092 | 0.355 | DNA damaging | 0.174 0.14 DBMET03367 0.355 0.04 DBMET03365 0.315 0.051 DBMET03366 0.241 0.085 DB12148 0.228 0.095 DBMET03368 | DBMET03365 | |
| 0.182 | 0.047 | 0.332 | MAO inhibitor | 0.097 0.094 DBMET03367 0.192 0.043 DBMET03365 0.18 0.048 DBMET03366 0.332 0.017 DB12148 | DB12148 | |
| 0.159 | 0.025 | 0.191 | Ca2+-transporting ATPase inhibitor | 0.161 0.023 DBMET03367 0.191 0.004 DBMET03365 0.183 0.006 DBMET03366 0.162 0.02 DB12148 0.16 0.024 DBMET03368 | DBMET03365 | |
| 0.158 | 0.04 | 0.158 | Cathepsin H inhibitor | 0.135 0.059 DBMET03365 0.124 0.07 DBMET03366 0.105 0.097 DB12148 0.112 0.086 DBMET03368 | ||
| 0.134 | 0.017 | 0.162 | Ornithine decarboxylase inhibitor | 0.126 0.022 DBMET03367 0.133 0.018 DBMET03365 0.162 0.008 DBMET03366 0.133 0.018 DB12148 0.139 0.015 DBMET03368 | DBMET03366 | |
| 0.191 | 0.076 | 0.377 | Platelet adhesion inhibitor | 0.377 0.014 DBMET03367 0.141 0.117 DBMET03365 0.334 0.024 DBMET03366 0.345 0.021 DB12148 0.187 0.078 DBMET03368 | DBMET03367 | |
| 0.129 | 0.015 | 0.129 | Vanilloid agonist | 0.106 0.027 DBMET03367 0.097 0.036 DBMET03366 0.128 0.015 DB12148 0.105 0.028 DBMET03368 | ||
| 0.249 | 0.136 | 0.29 | Vasodilator, coronary | 0.231 0.153 DBMET03367 0.268 0.116 DBMET03365 0.29 0.096 DBMET03366 0.192 0.189 DB12148 0.262 0.122 DBMET03368 | DBMET03366 | |
| 0.133 | 0.02 | 0.203 | Inducible nitric-oxide synthase inhibitor | 0.078 0.065 DBMET03367 0.203 0.008 DBMET03365 0.145 0.017 DBMET03366 0.171 0.012 DB12148 0.17 0.012 DBMET03368 | DBMET03365 | |
| 0.165 | 0.057 | 0.175 | Thiol protease inhibitor | 0.175 0.051 DBMET03367 0.147 0.071 DBMET03365 0.136 0.086 DBMET03366 | DBMET03367 | |
| 0.162 | 0.055 | 0.228 | Cell wall synthesis inhibitor | 0.171 0.047 DBMET03367 0.17 0.047 DBMET03365 0.18 0.04 DBMET03366 0.154 0.062 DB12148 0.228 0.021 DBMET03368 | DBMET03368 | |
| 0.207 | 0.101 | 0.537 | Aldehyde oxidase inhibitor | 0.244 0.084 DBMET03367 0.537 0.028 DBMET03365 0.402 0.047 DBMET03366 0.198 0.106 DB12148 0.194 0.108 DBMET03368 | DBMET03365 | |
| 0.146 | 0.04 | 0.176 | Microtubule formation inhibitor | 0.15 0.037 DBMET03367 0.175 0.027 DBMET03365 0.171 0.028 DBMET03366 0.163 0.031 DB12148 0.176 0.027 DBMET03368 | DBMET03368 | |
| 0.122 | 0.021 | 0.122 | Glutamate release inhibitor | 0.087 0.07 DBMET03367 0.089 0.063 DBMET03365 0.114 0.027 DBMET03366 0.1 0.043 DBMET03368 | ||
| 0.138 | 0.039 | 0.18 | Photosensitizer | 0.125 0.051 DBMET03367 0.146 0.033 DBMET03365 0.18 0.018 DBMET03366 0.107 0.076 DB12148 0.145 0.034 DBMET03368 | DBMET03366 | |
| 0.105 | 0.008 | 0.198 | Aldosterone antagonist | 0.066 0.016 DBMET03367 0.074 0.013 DBMET03365 0.119 0.007 DBMET03366 0.198 0.004 DB12148 0.058 0.021 DBMET03368 | DB12148 | |
| 0.096 | 0.004 | 0.143 | Pregnane X receptor antagonist | 0.089 0.004 DBMET03367 0.104 0.003 DBMET03365 0.143 0.002 DBMET03366 0.128 0.002 DB12148 0.089 0.004 DBMET03368 | DBMET03366 | |
| 0.145 | 0.053 | 0.182 | Cyclooxygenase 3 inhibitor | 0.144 0.054 DBMET03367 0.147 0.051 DBMET03365 0.182 0.026 DBMET03366 0.181 0.027 DB12148 0.156 0.043 DBMET03368 | DBMET03366 | |
| 0.113 | 0.023 | 0.113 | 3C-Like protease (SARS coronavirus) inhibitor | 0.087 0.052 DBMET03367 0.086 0.054 DBMET03366 0.085 0.056 DBMET03368 | ||
| 0.246 | 0.158 | 0.42 | GABA C receptor rho-3 antagonist | 0.42 0.053 DBMET03365 0.355 0.083 DBMET03366 0.394 0.064 DB12148 | DBMET03365 | |
| 0.219 | 0.131 | 0.405 | Hypoxia-inducible factor 1 alpha inhibitor | 0.272 0.082 DBMET03367 0.333 0.051 DBMET03365 0.382 0.035 DBMET03366 0.405 0.029 DB12148 | DB12148 | |
| 0.094 | 0.007 | 0.115 | Glucose-6-phosphate translocase inhibitor | 0.075 0.013 DBMET03367 0.061 0.023 DBMET03365 0.079 0.011 DBMET03366 0.098 0.006 DB12148 0.115 0.005 DBMET03368 | DBMET03368 | |
| 0.097 | 0.01 | 0.108 | Exportin-1 inhibitor | 0.088 0.016 DBMET03365 0.088 0.017 DBMET03366 0.108 0.006 DB12148 0.071 0.041 DBMET03368 | DB12148 | |
| 0.145 | 0.059 | 0.241 | Cyclooxygenase 1 inhibitor | 0.105 0.095 DBMET03367 0.17 0.048 DBMET03365 0.203 0.033 DBMET03366 0.241 0.023 DB12148 0.147 0.058 DBMET03368 | DB12148 | |
| 0.136 | 0.051 | 0.141 | Beta amyloid protein antagonist | 0.122 0.065 DBMET03366 0.141 0.047 DB12148 | DB12148 | |
| 0.168 | 0.084 | 0.291 | Succinate dehydrogenase inhibitor | 0.201 0.048 DBMET03367 0.291 0.012 DBMET03365 0.262 0.019 DBMET03366 0.154 0.104 DB12148 0.284 0.013 DBMET03368 | DBMET03365 | |
| 0.122 | 0.04 | 0.122 | Sphingomyelinase inhibitor | 0.116 0.044 DBMET03367 0.086 0.077 DBMET03365 0.093 0.068 DB12148 | ||
| 0.107 | 0.025 | 0.119 | Na+ K+ transporting ATPase inhibitor | 0.114 0.02 DBMET03367 0.099 0.033 DBMET03365 0.114 0.02 DBMET03366 0.119 0.017 DB12148 0.108 0.024 DBMET03368 | DB12148 | |
| 0.108 | 0.03 | 0.122 | Glutathione S-transferase inhibitor | 0.096 0.041 DBMET03367 0.09 0.048 DBMET03365 0.122 0.022 DBMET03366 0.105 0.033 DBMET03368 | DBMET03366 | |
| 0.099 | 0.021 | 0.144 | Glycine receptor agonist | 0.107 0.017 DBMET03367 0.088 0.03 DBMET03365 0.144 0.008 DBMET03366 0.11 0.016 DB12148 0.115 0.014 DBMET03368 | DBMET03366 | |
| 0.152 | 0.076 | 0.328 | Diuretic | 0.181 0.053 DBMET03367 0.186 0.05 DBMET03365 0.328 0.018 DBMET03366 0.196 0.046 DB12148 0.317 0.02 DBMET03368 | DBMET03366 | |
| 0.106 | 0.032 | 0.106 | ATPase (Vacuolar H+) inhibitor | 0.098 0.043 DBMET03367 0.096 0.045 DBMET03365 0.105 0.033 DBMET03366 0.095 0.047 DB12148 0.1 0.04 DBMET03368 | ||
| 0.109 | 0.034 | 0.144 | Topoisomerase II alpha inhibitor | 0.097 0.041 DBMET03367 0.144 0.024 DBMET03365 0.117 0.031 DBMET03366 0.143 0.024 DB12148 0.093 0.044 DBMET03368 | DBMET03365 | |
| 0.118 | 0.044 | 0.181 | Gastric antisecretory | 0.127 0.038 DBMET03366 0.181 0.016 DB12148 | DB12148 | |
| 0.078 | 0.005 | 0.078 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.059 0.008 DBMET03367 0.058 0.008 DB12148 0.045 0.015 DBMET03368 | ||
| 0.101 | 0.03 | 0.128 | Keratolytic | 0.113 0.024 DBMET03367 0.128 0.019 DBMET03365 0.105 0.028 DBMET03366 0.07 0.064 DB12148 0.107 0.027 DBMET03368 | DBMET03365 | |
| 0.078 | 0.007 | 0.214 | Inosine monophosphate dehydrogenase inhibitor | 0.046 0.017 DBMET03367 0.085 0.006 DBMET03365 0.214 0.003 DBMET03366 0.127 0.004 DB12148 0.056 0.012 DBMET03368 | DBMET03366 | |
| 0.158 | 0.088 | 0.18 | ATPase inhibitor | 0.18 0.058 DBMET03365 0.153 0.097 DBMET03366 0.15 0.102 DB12148 | DBMET03365 | |
| 0.077 | 0.008 | 0.108 | Retinoid X receptor agonist | 0.066 0.012 DBMET03367 0.108 0.004 DBMET03365 0.106 0.004 DBMET03366 0.059 0.014 DB12148 0.096 0.005 DBMET03368 | DBMET03365 | |
| 0.093 | 0.025 | 0.217 | Leukotriene antagonist | 0.097 0.023 DBMET03367 0.121 0.015 DBMET03365 0.164 0.009 DBMET03366 0.076 0.035 DB12148 0.217 0.005 DBMET03368 | DBMET03368 | |
| 0.118 | 0.051 | 0.316 | MAO B inhibitor | 0.114 0.053 DBMET03365 0.138 0.042 DBMET03366 0.316 0.012 DB12148 | DB12148 | |
| 0.105 | 0.039 | 0.144 | Bile acid receptor antagonist | 0.1 0.05 DBMET03367 0.118 0.021 DBMET03365 0.144 0.009 DBMET03366 0.128 0.014 DB12148 0.11 0.032 DBMET03368 | DBMET03366 | |
| 0.125 | 0.061 | 0.125 | Proteasome inhibitor | 0.098 0.089 DBMET03367 | ||
| 0.1 | 0.036 | 0.275 | CYP2A6 inhibitor | 0.128 0.024 DBMET03365 0.135 0.021 DBMET03366 0.275 0.004 DB12148 | DB12148 | |
| 0.076 | 0.013 | 0.125 | Farnesyltransferase inhibitor | 0.05 0.028 DBMET03367 0.058 0.021 DBMET03366 0.125 0.005 DB12148 0.074 0.014 DBMET03368 | DB12148 | |
| 0.087 | 0.025 | 0.21 | Peroxisome proliferator-activated receptor gamma antagonist | 0.087 0.025 DBMET03367 0.159 0.005 DBMET03365 0.21 0.004 DBMET03366 0.143 0.006 DB12148 0.145 0.006 DBMET03368 | DBMET03366 | |
| 0.092 | 0.031 | 0.175 | Leukotriene synthesis inhibitor | 0.078 0.038 DBMET03367 0.165 0.007 DBMET03365 0.175 0.007 DBMET03366 0.139 0.011 DB12148 0.122 0.016 DBMET03368 | DBMET03366 | |
| 0.069 | 0.008 | 0.072 | Geranyltranstransferase inhibitor | 0.058 0.015 DBMET03367 0.053 0.019 DBMET03366 0.072 0.007 DB12148 0.059 0.014 DBMET03368 | DB12148 | |
| 0.079 | 0.023 | 0.091 | Nitric oxide donor | 0.072 0.03 DBMET03367 0.07 0.033 DBMET03365 0.091 0.014 DBMET03366 0.089 0.015 DB12148 0.085 0.018 DBMET03368 | DBMET03366 | |
| 0.106 | 0.051 | 0.156 | Nitric-oxide synthase inhibitor | 0.156 0.02 DBMET03365 0.119 0.038 DBMET03366 0.148 0.023 DB12148 0.112 0.044 DBMET03368 | DBMET03365 | |
| 0.159 | 0.105 | 0.306 | Non-steroidal antiinflammatory agent | 0.167 0.098 DBMET03367 0.254 0.041 DBMET03365 0.306 0.027 DBMET03366 0.223 0.056 DB12148 0.231 0.051 DBMET03368 | DBMET03366 | |
| 0.058 | 0.004 | 0.065 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.046 0.005 DBMET03367 0.035 0.007 DBMET03365 0.064 0.004 DBMET03366 0.065 0.004 DB12148 0.047 0.005 DBMET03368 | DB12148 | |
| 0.102 | 0.048 | 0.167 | ABCA1 expression enhancer | 0.167 0.014 DBMET03367 0.109 0.04 DBMET03365 0.102 0.048 DBMET03366 0.135 0.022 DBMET03368 | DBMET03367 | |
| 0.068 | 0.015 | 0.082 | Squalene epoxidase inhibitor | 0.052 0.031 DBMET03367 0.082 0.009 DB12148 0.047 0.041 DBMET03368 | DB12148 | |
| 0.119 | 0.067 | 0.206 | Topoisomerase II inhibitor | 0.105 0.081 DBMET03367 0.206 0.032 DBMET03365 0.178 0.039 DBMET03366 0.204 0.032 DB12148 0.106 0.08 DBMET03368 | DBMET03365 | |
| 0.157 | 0.106 | 0.202 | Anesthetic general | 0.146 0.118 DBMET03367 0.177 0.089 DBMET03365 0.202 0.073 DBMET03366 0.186 0.083 DBMET03368 | DBMET03366 | |
| 0.091 | 0.042 | 0.128 | Glycine receptor antagonist | 0.078 0.06 DBMET03365 0.115 0.021 DBMET03366 0.128 0.014 DB12148 0.08 0.056 DBMET03368 | DB12148 | |
| 0.069 | 0.02 | 0.171 | Leukotriene B4 antagonist | 0.08 0.015 DBMET03367 0.095 0.011 DBMET03365 0.135 0.006 DBMET03366 0.068 0.021 DB12148 0.171 0.004 DBMET03368 | DBMET03368 | |
| 0.087 | 0.039 | 0.161 | GABA aminotransferase inhibitor | 0.069 0.064 DBMET03367 0.161 0.006 DBMET03365 0.159 0.006 DBMET03366 0.119 0.017 DBMET03368 | DBMET03365 | |
| 0.076 | 0.029 | 0.172 | Prostaglandin EP2 antagonist | 0.065 0.037 DBMET03367 0.123 0.014 DBMET03365 0.172 0.008 DBMET03366 0.059 0.042 DB12148 0.124 0.014 DBMET03368 | DBMET03366 | |
| 0.066 | 0.019 | 0.068 | Adenine nucleotide translocase inhibitor | 0.062 0.025 DBMET03367 0.068 0.017 DBMET03368 | DBMET03368 | |
| 0.049 | 0.007 | 0.072 | Cholesterol ester transfer protein antagonist | 0.044 0.01 DBMET03367 0.036 0.016 DBMET03365 0.06 0.005 DBMET03366 0.072 0.004 DB12148 0.03 0.024 DBMET03368 | DB12148 | |
| 0.065 | 0.023 | 0.097 | Dihydroorotate oxidase inhibitor | 0.056 0.036 DBMET03367 0.097 0.005 DBMET03365 0.075 0.013 DBMET03366 0.083 0.009 DB12148 0.057 0.035 DBMET03368 | DBMET03365 | |
| 0.102 | 0.06 | 0.146 | Butyrylcholinesterase inhibitor | 0.146 0.036 DB12148 | DB12148 | |
| 0.054 | 0.013 | 0.075 | Membrane dipeptidase inhibitor | 0.046 0.019 DBMET03367 0.058 0.011 DBMET03365 0.056 0.012 DBMET03366 0.037 0.032 DB12148 0.075 0.006 DBMET03368 | DBMET03368 | |
| 0.084 | 0.046 | 0.085 | Interferon agonist | 0.085 0.045 DBMET03367 0.08 0.052 DBMET03365 0.073 0.064 DBMET03366 0.074 0.062 DBMET03368 | DBMET03367 | |
| 0.071 | 0.036 | 0.071 | Protease 3C (Human rhinovirus) inhibitor | 0.064 0.045 DBMET03365 0.061 0.051 DBMET03366 | ||
| 0.135 | 0.1 | 0.193 | Interferon gamma antagonist | 0.136 0.099 DBMET03367 0.173 0.055 DBMET03365 0.193 0.043 DBMET03366 0.134 0.103 DB12148 0.144 0.086 DBMET03368 | DBMET03366 | |
| 0.049 | 0.015 | 0.135 | Retinoid X alpha receptor agonist | 0.039 0.021 DBMET03367 0.135 0.003 DBMET03365 0.13 0.004 DBMET03366 0.076 0.008 DB12148 0.073 0.008 DBMET03368 | DBMET03365 | |
| 0.081 | 0.047 | 0.102 | Estrogen receptor alpha antagonist | 0.075 0.057 DBMET03367 0.102 0.026 DBMET03365 0.102 0.026 DBMET03366 0.094 0.031 DB12148 | DBMET03366 | |
| 0.048 | 0.014 | 0.077 | Retinoid X receptor antagonist | 0.047 0.015 DBMET03367 0.068 0.004 DBMET03365 0.077 0.003 DBMET03366 0.065 0.005 DB12148 0.059 0.006 DBMET03368 | DBMET03366 | |
| 0.13 | 0.099 | 0.135 | Pregnane X receptor agonist | 0.135 0.085 DBMET03365 0.131 0.096 DBMET03366 0.135 0.085 DB12148 | DB12148 | |
| 0.06 | 0.03 | 0.06 | Elastase inhibitor | 0.05 0.042 DBMET03367 | ||
| 0.074 | 0.045 | 0.175 | Peroxisome proliferator-activated receptor gamma agonist | 0.075 0.044 DBMET03367 0.173 0.009 DBMET03365 0.175 0.009 DBMET03366 0.127 0.018 DB12148 0.162 0.01 DBMET03368 | DBMET03366 | |
| 0.035 | 0.006 | 0.132 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.023 0.011 DBMET03367 0.048 0.005 DBMET03365 0.132 0.003 DBMET03366 0.06 0.004 DB12148 0.029 0.008 DBMET03368 | DBMET03366 | |
| 0.042 | 0.013 | 0.065 | Retinoid X alpha receptor antagonist | 0.041 0.014 DBMET03367 0.059 0.004 DBMET03365 0.065 0.003 DBMET03366 0.057 0.004 DB12148 0.051 0.006 DBMET03368 | DBMET03366 | |
| 0.041 | 0.013 | 0.064 | HMG CoA reductase inhibitor | 0.047 0.009 DBMET03367 0.04 0.014 DBMET03365 0.051 0.007 DBMET03366 0.046 0.009 DB12148 0.064 0.004 DBMET03368 | DBMET03368 | |
| 0.113 | 0.086 | 0.151 | Acetylcholinesterase inhibitor | 0.151 0.054 DB12148 | DB12148 | |
| 0.058 | 0.031 | 0.072 | Acetyl-CoA transferase inhibitor | 0.072 0.024 DB12148 | DB12148 | |
| 0.049 | 0.024 | 0.049 | Leukocyte elastase inhibitor | 0.046 0.027 DBMET03366 0.04 0.033 DBMET03368 | ||
| 0.063 | 0.04 | 0.082 | Neuraminidase inhibitor | 0.076 0.028 DBMET03367 0.069 0.034 DBMET03365 0.074 0.03 DBMET03366 0.082 0.024 DB12148 0.056 0.049 DBMET03368 | DB12148 | |
| 0.033 | 0.009 | 0.033 | 1,3-Beta-glucan synthase inhibitor | 0.031 0.013 DBMET03367 0.03 0.014 DBMET03368 | ||
| 0.053 | 0.03 | 0.053 | Bombesin 2 receptor antagonist | 0.045 0.043 DBMET03365 0.046 0.041 DBMET03366 0.046 0.04 DBMET03368 | ||
| 0.036 | 0.014 | 0.076 | Leukotriene B4 receptor 1 antagonist | 0.035 0.014 DBMET03367 0.065 0.005 DBMET03365 0.065 0.005 DBMET03366 0.029 0.019 DB12148 0.076 0.004 DBMET03368 | DBMET03368 | |
| 0.065 | 0.043 | 0.065 | Interferon inducer | 0.065 0.044 DBMET03367 0.06 0.053 DBMET03365 | ||
| 0.074 | 0.054 | 0.074 | Vanilloid 4 agonist | |||
| 0.059 | 0.041 | 0.135 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.078 0.026 DBMET03365 0.135 0.009 DBMET03366 0.118 0.012 DB12148 0.068 0.032 DBMET03368 | DBMET03366 | |
| 0.137 | 0.119 | 0.311 | DNA methyltransferase I inhibitor | 0.297 0.027 DBMET03365 0.311 0.022 DBMET03366 0.238 0.052 DB12148 0.151 0.102 DBMET03368 | DBMET03366 | |
| 0.126 | 0.11 | 0.176 | Adenylate cyclase stimulant | 0.125 0.112 DBMET03367 0.167 0.039 DBMET03365 0.176 0.029 DBMET03366 0.133 0.094 DB12148 0.134 0.093 DBMET03368 | DBMET03366 | |
| 0.09 | 0.074 | 0.09 | Protease inhibitor | 0.087 0.078 DBMET03368 | ||
| 0.141 | 0.126 | 0.141 | Neurotensin receptor agonist | 0.139 0.133 DBMET03368 | ||
| 0.041 | 0.028 | 0.044 | Cathepsin L2 inhibitor | 0.038 0.03 DBMET03365 0.044 0.026 DB12148 | DB12148 | |
| 0.087 | 0.074 | 0.213 | MAO A inhibitor | 0.12 0.052 DBMET03365 0.098 0.065 DBMET03366 0.213 0.027 DB12148 | DB12148 | |
| 0.169 | 0.155 | 0.227 | RNA-directed DNA polymerase inhibitor | 0.227 0.067 DBMET03365 0.204 0.093 DBMET03366 0.224 0.07 DB12148 | DBMET03365 | |
| 0.096 | 0.083 | 0.184 | Mucolytic | 0.111 0.064 DBMET03367 0.179 0.019 DBMET03365 0.184 0.018 DBMET03366 0.113 0.061 DB12148 0.13 0.046 DBMET03368 | DBMET03366 | |
| 0.059 | 0.048 | 0.091 | Transcription factor AP-1 inhibitor | 0.091 0.016 DBMET03365 0.063 0.039 DBMET03366 0.064 0.039 DBMET03368 | DBMET03365 | |
| 0.138 | 0.127 | 0.283 | Psychostimulant | 0.211 0.074 DBMET03365 0.283 0.047 DBMET03366 0.168 0.102 DBMET03368 | DBMET03366 | |
| 0.025 | 0.014 | 0.035 | Retinoic acid receptor agonist | 0.024 0.014 DBMET03367 0.035 0.008 DBMET03365 0.034 0.008 DBMET03366 0.033 0.009 DB12148 0.027 0.012 DBMET03368 | DBMET03365 | |
| 0.089 | 0.079 | 0.127 | Phosphodiesterase 6D inhibitor | 0.09 0.076 DBMET03366 0.127 0.02 DB12148 | DB12148 | |
| 0.112 | 0.102 | 0.134 | Histone deacetylase SIRT1 inhibitor | 0.121 0.09 DBMET03366 0.134 0.076 DB12148 | DB12148 | |
| 0.036 | 0.027 | 0.066 | 5-Alpha-reductase inhibitor | 0.039 0.024 DBMET03367 0.066 0.014 DBMET03365 0.06 0.016 DBMET03366 0.047 0.02 DBMET03368 | DBMET03365 | |
| 0.064 | 0.055 | 0.106 | Glutamate (mGluR6) antagonist | 0.065 0.052 DBMET03367 0.087 0.017 DBMET03365 0.096 0.012 DBMET03366 0.106 0.008 DBMET03368 | DBMET03368 | |
| 0.021 | 0.014 | 0.021 | Neuraminidase (Influenza B) inhibitor | 0.02 0.018 DBMET03366 0.02 0.018 DB12148 | ||
| 0.03 | 0.023 | 0.068 | Prostaglandin agonist | 0.032 0.02 DBMET03367 0.031 0.021 DBMET03365 0.068 0.008 DBMET03366 0.044 0.012 DBMET03368 | DBMET03366 | |
| 0.189 | 0.182 | 0.257 | Angiogenesis inhibitor | 0.222 0.146 DBMET03365 0.257 0.118 DB12148 | DB12148 | |
| 0.055 | 0.049 | 0.062 | Lipocortins synthesis agonist | 0.059 0.039 DBMET03367 0.062 0.032 DBMET03366 0.058 0.041 DB12148 0.056 0.044 DBMET03368 | DBMET03366 | |
| 0.048 | 0.042 | 0.108 | Aconitate hydratase inhibitor | 0.048 0.043 DBMET03367 0.102 0.008 DBMET03365 0.108 0.007 DBMET03366 0.093 0.01 DBMET03368 | DBMET03366 | |
| 0.028 | 0.023 | 0.045 | Prostaglandin EP3 antagonist | 0.031 0.021 DBMET03365 0.045 0.011 DBMET03366 0.032 0.019 DBMET03368 | DBMET03366 | |
| 0.196 | 0.192 | 0.196 | Calpain 2 inhibitor | |||
| 0.134 | 0.131 | 0.182 | Interleukin antagonist | 0.176 0.099 DBMET03365 0.182 0.095 DBMET03366 | DBMET03366 | |
| 0.051 | 0.047 | 0.112 | Aromatase inhibitor | 0.075 0.03 DBMET03365 0.067 0.036 DBMET03366 0.112 0.019 DB12148 | DB12148 | |
| 0.019 | 0.016 | 0.151 | Peroxisome proliferator-activated receptor alpha antagonist | 0.023 0.014 DBMET03367 0.053 0.008 DBMET03365 0.151 0.004 DBMET03366 0.1 0.005 DB12148 0.084 0.005 DBMET03368 | DBMET03366 | |
| 0.068 | 0.067 | 0.115 | Phosphodiesterase VI inhibitor | 0.115 0.014 DB12148 | DB12148 | |
| 0.077 | 0.076 | 0.098 | Estrogen-related receptor beta agonist | 0.098 0.028 DBMET03367 0.082 0.06 DBMET03365 0.083 0.057 DBMET03366 0.079 0.069 DBMET03368 | DBMET03367 | |
| 0.086 | 0.085 | 0.128 | Anabolic | 0.125 0.035 DBMET03365 0.127 0.033 DBMET03366 0.128 0.032 DB12148 0.086 0.085 DBMET03368 | DB12148 | |
| 0.048 | 0.048 | 0.076 | Vanilloid 2 antagonist | 0.048 0.046 DBMET03366 0.076 0.011 DB12148 | DB12148 | |
| 0.1 | 0.1 | 0.114 | Estrogen antagonist | 0.104 0.088 DBMET03367 0.113 0.068 DBMET03365 0.114 0.067 DBMET03366 0.103 0.092 DB12148 0.101 0.097 DBMET03368 | DBMET03366 | |
| 0.025 | 0.026 | 0.036 | Retinoid X gamma receptor antagonist | 0.026 0.022 DBMET03367 0.035 0.007 DBMET03365 0.036 0.006 DBMET03366 0.028 0.016 DB12148 0.03 0.012 DBMET03368 | DBMET03366 | |
| 0.087 | 0.089 | 0.105 | Estrogen receptor beta antagonist | 0.105 0.056 DBMET03365 0.105 0.056 DBMET03366 0.098 0.067 DB12148 | DBMET03366 | |
| 0.051 | 0.055 | 0.059 | Androgen agonist | 0.053 0.052 DBMET03365 0.059 0.043 DBMET03368 | DBMET03368 | |
| 0.114 | 0.118 | 0.242 | Thrombolytic | 0.133 0.096 DBMET03367 0.118 0.113 DBMET03365 0.193 0.055 DBMET03366 0.12 0.11 DB12148 0.242 0.036 DBMET03368 | DBMET03368 | |
| 0.018 | 0.023 | 0.035 | Retinoid X beta receptor antagonist | 0.031 0.004 DBMET03365 0.035 0.004 DBMET03366 0.022 0.011 DB12148 0.023 0.009 DBMET03368 | DBMET03366 | |
| 0.079 | 0.083 | 0.153 | Aminopeptidase B inhibitor | 0.107 0.06 DBMET03365 0.101 0.064 DBMET03366 0.153 0.036 DBMET03368 | DBMET03368 | |
| 0.02 | 0.025 | 0.047 | Leukotriene D4 antagonist | 0.026 0.018 DBMET03365 0.047 0.011 DBMET03366 0.043 0.011 DBMET03368 | DBMET03366 | |
| 0.042 | 0.048 | 0.103 | Dihydroorotate dehydrogenase inhibitor | 0.046 0.042 DBMET03367 0.069 0.022 DBMET03365 0.077 0.019 DBMET03366 0.103 0.01 DB12148 | DB12148 | |
| 0.061 | 0.068 | 0.088 | Aminopeptidase I inhibitor | 0.087 0.036 DBMET03365 0.088 0.035 DBMET03366 0.084 0.038 DBMET03368 | DBMET03366 | |
| 0.095 | 0.102 | 0.206 | Cell adhesion inhibitor | 0.149 0.047 DBMET03365 0.206 0.023 DBMET03366 0.193 0.026 DBMET03368 | DBMET03366 | |
| 0.078 | 0.085 | 0.147 | Breast cancer-resistant protein inhibitor | 0.085 0.072 DBMET03366 0.147 0.025 DB12148 | DB12148 | |
| 0.056 | 0.064 | 0.064 | Neuraminidase (influenza) inhibitor | 0.062 0.049 DBMET03367 0.061 0.051 DBMET03365 0.064 0.045 DBMET03366 0.064 0.045 DB12148 | DB12148 | |
| 0.011 | 0.019 | 0.016 | Prostacyclin agonist | 0.014 0.012 DBMET03366 0.016 0.01 DBMET03368 | DBMET03368 | |
| 0.044 | 0.053 | 0.103 | CD45 antagonist | 0.048 0.04 DBMET03365 0.103 0.009 DBMET03366 0.051 0.032 DB12148 0.048 0.04 DBMET03368 | DBMET03366 | |
| 0.017 | 0.027 | 0.044 | Leukotriene B4 receptor 2 antagonist | 0.044 0.005 DBMET03365 0.035 0.006 DBMET03366 0.02 0.018 DBMET03368 | DBMET03365 | |
| 0.046 | 0.058 | 0.09 | Thromboxane synthase inhibitor | 0.054 0.038 DBMET03367 0.082 0.011 DBMET03365 0.09 0.008 DBMET03366 0.085 0.01 DBMET03368 | DBMET03366 | |
| 0.061 | 0.073 | 0.139 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.139 0.022 DBMET03365 0.119 0.029 DBMET03366 0.067 0.064 DB12148 | DBMET03365 | |
| 0.042 | 0.054 | 0.048 | Maillard reaction inhibitor | 0.048 0.046 DBMET03366 | DBMET03366 | |
| 0.048 | 0.06 | 0.052 | Calcium channel T-type blocker | 0.052 0.051 DB12148 | DB12148 | |
| 0.044 | 0.057 | 0.148 | HIV-1 integrase (Strand Transfer) inhibitor | 0.148 0.013 DBMET03365 0.077 0.032 DBMET03366 0.061 0.041 DBMET03368 | DBMET03365 | |
| 0.014 | 0.028 | 0.036 | Geranylgeranyltransferase I inhibitor | 0.036 0.006 DB12148 | DB12148 | |
| 0.018 | 0.033 | 0.045 | Prostaglandin EP4 antagonist | 0.028 0.016 DBMET03365 0.045 0.009 DBMET03366 0.036 0.012 DBMET03368 | DBMET03366 | |
| 0.035 | 0.05 | 0.119 | Peroxisome proliferator-activated receptor alpha agonist | 0.104 0.011 DBMET03365 0.119 0.009 DBMET03366 0.058 0.027 DB12148 0.095 0.013 DBMET03368 | DBMET03366 | |
| 0.067 | 0.082 | 0.083 | Androgen antagonist | 0.083 0.062 DBMET03366 | DBMET03366 | |
| 0.035 | 0.05 | 0.064 | Kainate receptor agonist | 0.064 0.005 DBMET03365 0.048 0.016 DBMET03366 0.042 0.027 DB12148 0.062 0.006 DBMET03368 | DBMET03365 | |
| 0.007 | 0.023 | 0.07 | Prostaglandin EP4 agonist | 0.07 0.004 DBMET03366 0.013 0.012 DBMET03368 | DBMET03366 | |
| 0.043 | 0.059 | 0.063 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.063 0.027 DBMET03365 0.05 0.043 DBMET03366 0.048 0.046 DB12148 | DBMET03365 | |
| 0.057 | 0.074 | 0.101 | Cathepsin G inhibitor | 0.077 0.046 DBMET03365 0.101 0.033 DBMET03366 | DBMET03366 | |
| 0.023 | 0.043 | 0.042 | ATP citrate lysase inhibitor | 0.034 0.019 DBMET03365 0.042 0.012 DBMET03366 0.042 0.012 DBMET03368 | DBMET03368 | |
| 0.022 | 0.042 | 0.057 | Peroxisome proliferator-activated receptor delta agonist | 0.04 0.017 DBMET03365 0.057 0.011 DBMET03366 0.055 0.011 DBMET03368 | DBMET03366 | |
| 0.179 | 0.199 | 0.293 | 5 Hydroxytryptamine uptake stimulant | 0.257 0.074 DBMET03365 0.293 0.049 DBMET03366 0.201 0.149 DB12148 | DBMET03366 | |
| 0.072 | 0.092 | 0.089 | Thioredoxin reductase inhibitor | 0.084 0.052 DBMET03366 0.089 0.043 DB12148 | DB12148 | |
| 0.055 | 0.076 | 0.143 | Carbonic anhydrase XIII inhibitor | 0.073 0.056 DBMET03365 0.143 0.023 DBMET03366 | DBMET03366 | |
| 0.038 | 0.059 | 0.07 | Glucose-6-phosphate isomerase inhibitor | 0.048 0.032 DBMET03367 0.059 0.019 DBMET03365 0.07 0.013 DBMET03366 0.056 0.022 DBMET03368 | DBMET03366 | |
| 0.089 | 0.111 | 0.133 | Caspase 3 inhibitor | 0.099 0.093 DBMET03365 0.133 0.043 DBMET03366 | DBMET03366 | |
| 0.074 | 0.099 | 0.133 | Thioredoxin inhibitor | 0.133 0.023 DBMET03365 0.112 0.037 DBMET03366 0.09 0.062 DB12148 | DBMET03365 | |
| 0.08 | 0.105 | 0.227 | Cystathionine beta-synthase inhibitor | 0.227 0.019 DBMET03365 0.176 0.031 DBMET03366 0.126 0.054 DB12148 0.111 0.066 DBMET03368 | DBMET03365 | |
| 0.011 | 0.04 | 0.044 | Prostaglandin EP2 agonist | 0.044 0.007 DBMET03366 | DBMET03366 | |
| 0.083 | 0.112 | 0.186 | Alkylator | 0.107 0.08 DBMET03367 0.135 0.055 DBMET03365 0.186 0.03 DBMET03366 0.143 0.05 DB12148 | DBMET03366 | |
| 0.037 | 0.066 | 0.058 | H+/K+-transporting ATPase inhibitor | 0.058 0.027 DB12148 | DB12148 | |
| 0.015 | 0.044 | 0.025 | Prostaglandin F2 alpha agonist | 0.025 0.013 DBMET03366 | DBMET03366 | |
| 0.025 | 0.055 | 0.035 | Glutamate (mGluR3) agonist | 0.031 0.024 DBMET03365 0.035 0.017 DBMET03366 0.032 0.024 DBMET03368 | DBMET03366 | |
| 0.113 | 0.142 | 0.17 | Amyloid beta aggregation inhibitor | 0.17 0.094 DBMET03365 | DBMET03365 | |
| 0.012 | 0.043 | 0.04 | Prostaglandin E2 agonist | 0.04 0.007 DBMET03366 | DBMET03366 | |
| 0.01 | 0.041 | 0.026 | Retinoic acid receptor antagonist | 0.026 0.007 DBMET03365 | DBMET03365 | |
| 0.033 | 0.065 | 0.038 | VCAM-1 antagonist | 0.038 0.035 DBMET03368 | DBMET03368 | |
| 0.075 | 0.107 | 0.094 | Xanthine oxidase inhibitor | 0.094 0.066 DBMET03366 | DBMET03366 | |
| 0.033 | 0.065 | 0.038 | VCAM antagonist | 0.038 0.035 DBMET03368 | DBMET03368 | |
| 0.185 | 0.218 | 0.311 | Interleukin 2 agonist | 0.236 0.135 DBMET03367 0.256 0.113 DBMET03365 0.311 0.066 DBMET03366 0.266 0.102 DBMET03368 | DBMET03366 | |
| 0.02 | 0.054 | 0.055 | Nicotinic acid receptor agonist | 0.034 0.027 DBMET03366 0.055 0.013 DB12148 | DB12148 | |
| 0.021 | 0.059 | 0.059 | TRPM8 blocker | 0.059 0.012 DB12148 | DB12148 | |
| 0.072 | 0.111 | 0.173 | Expectorant | 0.158 0.032 DBMET03365 0.173 0.027 DBMET03366 0.101 0.068 DBMET03368 | DBMET03366 | |
| 0.04 | 0.08 | 0.061 | Fatty acid synthase inhibitor | 0.061 0.034 DB12148 | DB12148 | |
| 0.052 | 0.093 | 0.069 | Transcription factor RelA inhibitor | 0.062 0.048 DBMET03365 0.069 0.031 DB12148 | DB12148 | |
| 0.035 | 0.075 | 0.057 | Aminopeptidase microsomal inhibitor | 0.057 0.042 DBMET03368 | DBMET03368 | |
| 0.077 | 0.121 | 0.147 | Beta glucuronidase inhibitor | 0.101 0.068 DBMET03365 0.117 0.049 DBMET03366 0.147 0.026 DB12148 | DB12148 | |
| 0.011 | 0.056 | 0.039 | Retinoid X gamma receptor agonist | 0.039 0.007 DBMET03365 0.036 0.008 DBMET03366 | DBMET03365 | |
| 0.012 | 0.059 | 0.019 | Retinoic acid beta receptor agonist | 0.019 0.017 DBMET03365 | DBMET03365 | |
| 0.03 | 0.078 | 0.253 | Beta tubulin antagonist | 0.253 0.005 DBMET03365 | DBMET03365 | |
| 0.025 | 0.074 | 0.068 | Retinoic acid alpha receptor agonist | 0.068 0.007 DBMET03365 0.052 0.013 DBMET03366 0.037 0.032 DB12148 | DBMET03365 | |
| 0.015 | 0.065 | 0.022 | ICAM 1 antagonist | 0.022 0.019 DBMET03365 0.021 0.02 DBMET03368 | DBMET03365 | |
| 0.044 | 0.094 | 0.118 | Catalase inhibitor | 0.073 0.052 DBMET03365 0.118 0.033 DBMET03366 0.066 0.058 DBMET03368 | DBMET03366 | |
| 0.004 | 0.054 | 0.013 | Thromboxane agonist | 0.013 0.005 DBMET03366 | DBMET03366 | |
| 0.09 | 0.141 | 0.172 | Cyclooxygenase inhibitor | 0.172 0.055 DBMET03365 0.15 0.07 DBMET03366 0.159 0.063 DB12148 0.124 0.094 DBMET03368 | DBMET03365 | |
| 0.033 | 0.084 | 0.084 | Argininosuccinate synthase inhibitor | 0.083 0.024 DBMET03365 0.084 0.024 DBMET03366 0.069 0.031 DBMET03368 | DBMET03366 | |
| 0.04 | 0.093 | 0.144 | HIV-1 integrase (3'-Processing) inhibitor | 0.144 0.014 DBMET03365 0.059 0.048 DBMET03366 | DBMET03365 | |
| 0.062 | 0.116 | 0.121 | HIV-1 integrase (Overall Integration) inhibitor | 0.121 0.039 DBMET03365 0.092 0.063 DBMET03366 | DBMET03365 | |
| 0.038 | 0.092 | 0.126 | Phosphofructokinase-1 inhibitor | 0.122 0.024 DBMET03365 0.126 0.023 DBMET03366 0.089 0.036 DBMET03368 | DBMET03366 | |
| 0.049 | 0.104 | 0.066 | Glutamate (mGluR7) antagonist | 0.066 0.051 DBMET03365 0.062 0.059 DBMET03368 | DBMET03365 | |
| 0.024 | 0.083 | 0.041 | Antimetabolite | 0.041 0.039 DBMET03366 | DBMET03366 | |
| 0.111 | 0.171 | 0.272 | DNA methylase inhibitor | 0.263 0.042 DBMET03365 0.272 0.038 DBMET03366 0.193 0.084 DB12148 | DBMET03366 | |
| 0.008 | 0.069 | 0.023 | Retinoic acid alpha receptor antagonist | 0.023 0.01 DBMET03365 | DBMET03365 | |
| 0.121 | 0.182 | 0.179 | Phospholipase C inhibitor | 0.179 0.061 DBMET03365 0.173 0.069 DBMET03366 | DBMET03365 | |
| 0.009 | 0.071 | 0.034 | Retinoid X beta receptor agonist | 0.034 0.007 DBMET03365 0.031 0.008 DBMET03366 | DBMET03365 | |
| 0.022 | 0.087 | 0.036 | GABA uptake inhibitor | 0.036 0.033 DBMET03366 | DBMET03366 | |
| 0.015 | 0.083 | 0.092 | Fumarate hydratase inhibitor | 0.092 0.006 DBMET03365 0.072 0.008 DBMET03366 0.032 0.026 DBMET03368 | DBMET03365 | |
| 0.048 | 0.117 | 0.12 | HIV-1 integrase inhibitor | 0.12 0.015 DBMET03365 0.093 0.029 DBMET03366 | DBMET03365 | |
| 0.08 | 0.15 | 0.128 | Toll-Like receptor 2 antagonist | 0.103 0.099 DBMET03365 0.128 0.07 DBMET03366 0.121 0.076 DBMET03368 | DBMET03366 | |
| 0.013 | 0.085 | 0.034 | Prostaglandin D2 agonist | 0.034 0.017 DBMET03366 | DBMET03366 | |
| 0.144 | 0.218 | 0.296 | 12-Lipoxygenase inhibitor | 0.193 0.16 DBMET03365 0.247 0.111 DBMET03366 0.296 0.082 DB12148 | DB12148 | |
| 0.019 | 0.093 | 0.038 | Peroxisome proliferator-activated receptor delta antagonist | 0.038 0.016 DBMET03366 0.038 0.016 DBMET03368 | DBMET03368 | |
| 0.013 | 0.088 | 0.022 | Retinoic acid gamma receptor agonist | 0.022 0.015 DBMET03365 | DBMET03365 | |
| 0.004 | 0.079 | 0.017 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.017 0.009 DBMET03368 | DBMET03368 | |
| 0.005 | 0.082 | 0.012 | Retinoic acid receptor gamma antagonist | 0.012 0.008 DBMET03365 | DBMET03365 | |
| 0.054 | 0.131 | 0.108 | Topoisomerase I inhibitor | 0.108 0.064 DBMET03365 0.087 0.082 DBMET03366 | DBMET03365 | |
| 0.046 | 0.123 | 0.125 | Glutamate dehydrogenase inhibitor | 0.095 0.033 DBMET03365 0.125 0.021 DBMET03366 0.08 0.044 DBMET03368 | DBMET03366 | |
| 0.004 | 0.082 | 0.028 | G-protein-coupled receptor 120 agonist | 0.018 0.011 DBMET03365 0.028 0.005 DBMET03366 | DBMET03366 | |
| 0.056 | 0.139 | 0.095 | Prolactin inhibitor | 0.095 0.061 DBMET03366 | DBMET03366 | |
| 0.06 | 0.144 | 0.112 | Transcription factor NF kappa B stimulant | 0.081 0.068 DBMET03365 0.098 0.041 DBMET03366 0.112 0.03 DB12148 | DB12148 | |
| 0.004 | 0.088 | 0.012 | Retinoic acid beta receptor antagonist | 0.012 0.008 DBMET03365 | DBMET03365 | |
| 0.028 | 0.113 | 0.047 | DNA gyrase subunit A inhibitor | 0.047 0.022 DBMET03365 0.04 0.036 DBMET03366 0.039 0.037 DB12148 | DBMET03365 | |
| 0.063 | 0.153 | 0.099 | Interleukin 1 beta converting enzyme inhibitor | 0.099 0.059 DBMET03366 | DBMET03366 | |
| 0.058 | 0.149 | 0.3 | GABA C receptor agonist | 0.226 0.016 DBMET03365 0.3 0.009 DBMET03366 0.095 0.073 DBMET03368 | DBMET03366 | |
| 0.036 | 0.128 | 0.052 | Angiotensin-converting enzyme inhibitor | 0.052 0.043 DBMET03368 | DBMET03368 | |
| 0.073 | 0.167 | 0.198 | Aldehyde dehydrogenase inhibitor | 0.165 0.039 DBMET03365 0.198 0.028 DBMET03366 0.1 0.097 DB12148 | DBMET03366 | |
| 0.153 | 0.247 | 0.26 | Insulysin inhibitor | 0.22 0.129 DBMET03365 0.26 0.088 DBMET03366 | DBMET03366 | |
| 0.096 | 0.192 | 0.174 | GABA C receptor rho-2 antagonist | 0.174 0.047 DBMET03365 0.144 0.082 DBMET03366 0.145 0.081 DB12148 | DBMET03365 | |
| 0.024 | 0.121 | 0.057 | Lysophosphatidic acid 3 receptor antagonist | 0.049 0.038 DBMET03365 0.057 0.026 DBMET03366 | DBMET03366 | |
| 0.1 | 0.197 | 0.126 | Sphingosine 1-phosphate receptor 5 antagonist | 0.126 0.109 DBMET03365 | DBMET03365 | |
| 0.041 | 0.139 | 0.067 | Leukotriene C antagonist | 0.059 0.031 DBMET03365 0.067 0.017 DBMET03366 | DBMET03366 | |
| 0.016 | 0.116 | 0.037 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.037 0.02 DBMET03366 | DBMET03366 | |
| 0.16 | 0.26 | 0.33 | Antiobesity | 0.209 0.198 DBMET03367 0.225 0.181 DBMET03365 0.266 0.143 DBMET03366 0.33 0.097 DB12148 | DB12148 | |
| 0.026 | 0.129 | 0.046 | Integrin alpha1beta1 antagonist | 0.036 0.033 DBMET03366 0.046 0.011 DBMET03368 | DBMET03368 | |
| 0.034 | 0.139 | 0.084 | Phosphodiesterase 4D inhibitor | 0.084 0.044 DB12148 | DB12148 | |
| 0.079 | 0.188 | 0.224 | Angiogenesis stimulant | 0.224 0.082 DBMET03366 0.185 0.102 DBMET03368 | DBMET03366 | |
| 0.005 | 0.114 | 0.016 | Thromboxane A2 agonist | 0.016 0.011 DBMET03366 | DBMET03366 | |
| 0.123 | 0.235 | 0.24 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.24 0.047 DBMET03365 0.233 0.051 DBMET03366 0.17 0.108 DB12148 | DBMET03365 | |
| 0.034 | 0.147 | 0.149 | Glutamate decarboxylase inhibitor | 0.142 0.015 DBMET03365 0.149 0.013 DBMET03366 | DBMET03366 | |
| 0.02 | 0.134 | 0.076 | Thromboxane antagonist | 0.061 0.032 DBMET03365 0.076 0.022 DBMET03366 0.05 0.042 DBMET03368 | DBMET03366 | |
| 0.083 | 0.197 | 0.131 | Dual specificity phosphatase 3 inhibitor | 0.131 0.115 DBMET03368 | DBMET03368 | |
| 0.01 | 0.125 | 0.042 | Free fatty acid receptor 1 antagonist | 0.04 0.016 DBMET03365 0.042 0.014 DBMET03366 | DBMET03366 | |
| 0.009 | 0.127 | 0.031 | Kainate receptor 2 antagonist | 0.031 0.029 DBMET03368 | DBMET03368 | |
| 0.148 | 0.266 | 0.381 | Alpha-glucosidase inhibitor | 0.238 0.195 DBMET03365 0.381 0.123 DB12148 | DB12148 | |
| 0.026 | 0.145 | 0.044 | Leukotriene C4 antagonist | 0.038 0.031 DBMET03365 0.044 0.017 DBMET03366 | DBMET03366 | |
| 0.051 | 0.176 | 0.259 | Ferrochelatase inhibitor | 0.254 0.013 DBMET03365 0.259 0.012 DBMET03366 0.095 0.077 DB12148 | DBMET03366 | |
| 0.048 | 0.176 | 0.157 | Creatine kinase inhibitor | 0.157 0.021 DBMET03365 0.126 0.036 DBMET03366 0.087 0.076 DB12148 | DBMET03365 | |
| 0.016 | 0.149 | 0.068 | Thromboxane A2 antagonist | 0.059 0.029 DBMET03365 0.068 0.023 DBMET03366 | DBMET03366 | |
| 0.029 | 0.162 | 0.262 | Porphobilinogen synthase inhibitor | 0.202 0.012 DBMET03365 0.262 0.007 DBMET03366 | DBMET03366 | |
| 0.1 | 0.233 | 0.228 | Lipocortins synthesis antagonist | 0.19 0.063 DBMET03365 0.228 0.041 DBMET03366 0.147 0.109 DBMET03368 | DBMET03366 | |
| 0.054 | 0.189 | 0.129 | GABA C receptor rho-1 antagonist | 0.129 0.033 DBMET03365 0.103 0.058 DBMET03366 | DBMET03365 | |
| 0.061 | 0.197 | 0.125 | Alkaline phosphatase inhibitor | 0.125 0.081 DBMET03365 | DBMET03365 | |
| 0.084 | 0.221 | 0.216 | Growth hormone agonist | 0.216 0.053 DBMET03366 | DBMET03366 | |
| 0.05 | 0.188 | 0.182 | Triose-phosphate isomerase inhibitor | 0.148 0.021 DBMET03365 0.182 0.013 DBMET03366 | DBMET03366 | |
| 0.103 | 0.243 | 0.234 | Streptokinase A inhibitor | 0.234 0.113 DB12148 | DB12148 | |
| 0.049 | 0.189 | 0.131 | Chelator | 0.101 0.076 DBMET03365 0.131 0.045 DBMET03366 | DBMET03366 | |
| 0.062 | 0.204 | 0.122 | DOPA decarboxylase inhibitor | 0.122 0.042 DBMET03365 0.104 0.068 DBMET03366 | DBMET03365 | |
| 0.037 | 0.18 | 0.063 | Caspase 9 inhibitor | 0.063 0.042 DBMET03366 | DBMET03366 | |
| 0.062 | 0.205 | 0.148 | Adenylate kinase inhibitor | 0.131 0.036 DBMET03365 0.148 0.027 DBMET03366 | DBMET03366 | |
| 0.078 | 0.221 | 0.161 | Heat shock protein 90 antagonist | 0.161 0.064 DBMET03365 0.145 0.079 DB12148 | DBMET03365 | |
| 0.02 | 0.167 | 0.043 | Glutamate (mGluR8) agonist | 0.038 0.027 DBMET03365 0.043 0.018 DBMET03366 | DBMET03366 | |
| 0.052 | 0.201 | 0.118 | Cyclooxygenase 2 inhibitor | 0.118 0.081 DBMET03365 | DBMET03365 | |
| 0.058 | 0.208 | 0.149 | Toll-Like receptor 4 antagonist | 0.149 0.022 DBMET03365 0.091 0.087 DBMET03368 | DBMET03365 | |
| 0.02 | 0.173 | 0.039 | Glutamate (mGluR8) antagonist | 0.036 0.025 DBMET03366 0.039 0.018 DBMET03368 | DBMET03368 | |
| 0.062 | 0.219 | 0.111 | NADPH oxidase inhibitor | 0.111 0.094 DBMET03366 | DBMET03366 | |
| 0.05 | 0.209 | 0.126 | GABA C receptor antagonist | 0.126 0.046 DBMET03365 0.102 0.075 DBMET03366 | DBMET03365 | |
| 0.01 | 0.174 | 0.026 | Thyroid hormone agonist | 0.024 0.023 DBMET03365 0.026 0.018 DBMET03366 | DBMET03366 | |
| 0.074 | 0.238 | 0.185 | Mannose-6-phosphate isomerase inhibitor | 0.185 0.039 DBMET03365 0.148 0.066 DBMET03366 | DBMET03365 | |
| 0.05 | 0.22 | 0.102 | AMP-activated protein kinase stimulant | 0.102 0.068 DBMET03365 0.099 0.071 DBMET03366 0.102 0.068 DB12148 | DB12148 | |
| 0.046 | 0.217 | 0.133 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.122 0.038 DBMET03365 0.133 0.033 DBMET03366 | DBMET03366 | |
| 0.102 | 0.286 | 0.164 | Growth factor agonist | 0.164 0.113 DB12148 | DB12148 | |
| 0.011 | 0.198 | 0.025 | Glutamate (mGluR1) agonist | 0.025 0.015 DBMET03365 | DBMET03365 | |
| 0.074 | 0.262 | 0.242 | Interleukin agonist | 0.21 0.112 DBMET03365 0.242 0.085 DBMET03366 | DBMET03366 | |
| 0.041 | 0.237 | 0.226 | Tubulin antagonist | 0.226 0.03 DBMET03365 | DBMET03365 | |
| 0.013 | 0.209 | 0.078 | Aldose reductase inhibitor | 0.063 0.031 DBMET03365 0.078 0.024 DBMET03366 | DBMET03366 | |
| 0.025 | 0.225 | 0.069 | Phospholipase D inhibitor | 0.067 0.059 DBMET03366 0.069 0.054 DB12148 | DB12148 | |
| 0.015 | 0.219 | 0.095 | Alcohol oxidase inhibitor | 0.095 0.019 DBMET03365 0.06 0.036 DBMET03366 | DBMET03365 | |
| 0.054 | 0.263 | 0.152 | Aryl hydrocarbon receptor agonist | 0.152 0.134 DBMET03365 0.144 0.14 DB12148 | DBMET03365 | |
| 0.039 | 0.248 | 0.101 | UDP-glucose 4-epimerase inhibitor | 0.101 0.06 DBMET03365 | DBMET03365 | |
| 0.054 | 0.264 | 0.147 | Interleukin 1 antagonist | 0.147 0.059 DBMET03365 | DBMET03365 | |
| 0.016 | 0.232 | 0.079 | Biliverdin reductase inhibitor | 0.079 0.027 DBMET03365 0.075 0.029 DBMET03366 | DBMET03365 | |
| 0.039 | 0.257 | 0.097 | Cell adhesion molecule inhibitor | 0.097 0.037 DBMET03366 0.093 0.04 DBMET03368 | DBMET03366 | |
| 0.046 | 0.268 | 0.228 | Alpha-N-acetylglucosaminidase inhibitor | 0.228 0.027 DBMET03365 0.155 0.052 DBMET03366 | DBMET03365 | |
| 0.116 | 0.342 | 0.348 | Sodium/bile acid cotransporter inhibitor | 0.312 0.069 DBMET03365 0.348 0.041 DBMET03366 0.261 0.116 DBMET03368 | DBMET03366 | |
| 0.15 | 0.392 | 0.358 | Calcium channel L-type activator | 0.358 0.111 DBMET03365 0.301 0.157 DBMET03366 | DBMET03365 | |
| 0.011 | 0.253 | 0.078 | Prostaglandin antagonist | 0.046 0.043 DBMET03365 0.078 0.024 DBMET03366 | DBMET03366 | |
| 0.18 | 0.425 | 0.271 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.271 0.254 DBMET03365 | DBMET03365 | |
| 0.004 | 0.252 | 0.017 | Free fatty acid receptor 1 agonist | 0.017 0.013 DBMET03366 | DBMET03366 | |
| 0.056 | 0.312 | 0.202 | Amyloid beta precursor protein antagonist | 0.202 0.056 DBMET03367 | DBMET03367 | |
| 0.014 | 0.274 | 0.082 | Carbamoyl phosphate synthetase inhibitor | 0.06 0.043 DBMET03365 0.082 0.028 DBMET03366 | DBMET03366 | |
| 0.039 | 0.31 | 0.094 | NADH dehydrogenase inhibitor | 0.094 0.05 DBMET03365 | DBMET03365 | |
| 0.084 | 0.361 | 0.149 | Death-associated protein kinase 2 inhibitor | 0.149 0.109 DB12148 | DB12148 | |
| 0.024 | 0.303 | 0.096 | Alcohol dehydrogenase inhibitor | 0.081 0.078 DBMET03365 0.096 0.057 DBMET03366 | DBMET03366 | |
| 0.058 | 0.345 | 0.177 | Platelet aggregation inhibitor | 0.177 0.1 DBMET03366 | DBMET03366 | |
| 0.02 | 0.309 | 0.068 | Prostaglandin F2 alpha antagonist | 0.068 0.035 DBMET03366 | DBMET03366 | |
| 0.033 | 0.332 | 0.079 | GABA B receptor agonist | 0.079 0.044 DBMET03366 | DBMET03366 | |
| 0.011 | 0.313 | 0.047 | Plasminogen activator inhibitor antagonist | 0.047 0.036 DBMET03366 | DBMET03366 | |
| 0.018 | 0.322 | 0.04 | Glutamate (mGluR group III) antagonist | 0.04 0.039 DBMET03365 | DBMET03365 | |
| 0.073 | 0.395 | 0.281 | DNA directed DNA polymerase inhibitor | 0.281 0.172 DBMET03365 | DBMET03365 | |
| 0.089 | 0.413 | 0.131 | CC chemokine 6 receptor antagonist | 0.131 0.066 DBMET03365 | DBMET03365 | |
| 0.004 | 0.331 | 0.028 | Kynurenine 3 monooxygenase inhibitor | 0.028 0.017 DBMET03365 | DBMET03365 | |
| 0.014 | 0.342 | 0.07 | Histidine decarboxylase inhibitor | 0.07 0.05 DBMET03365 | DBMET03365 | |
| 0.034 | 0.367 | 0.142 | Pyruvate kinase inhibitor | 0.142 0.123 DBMET03365 | DBMET03365 | |
| 0.013 | 0.353 | 0.072 | Phenylalanine 4-hydroxylase inhibitor | 0.072 0.044 DBMET03365 0.066 0.05 DBMET03366 | DBMET03365 | |
| 0.03 | 0.408 | 0.09 | Electrolyte absorption antagonist | 0.09 0.074 DBMET03365 0.089 0.076 DBMET03366 | DBMET03365 | |
| 0.026 | 0.415 | 0.138 | Mcl-1 antagonist | 0.138 0.102 DBMET03365 | DBMET03365 | |
| 0.034 | 0.511 | 0.291 | Insulin secretagoues | 0.119 0.112 DBMET03367 0.291 0.014 DBMET03365 0.151 0.073 DBMET03366 | DBMET03365 | |
| 0.083 | 0.574 | 0.185 | Peptidyltransferase inhibitor | 0.185 0.12 DBMET03365 0.172 0.144 DBMET03366 | DBMET03365 | |
| 0.02 | 0.517 | 0.065 | DNA helicase inhibitor | 0.065 0.022 DBMET03365 0.054 0.038 DBMET03366 | DBMET03365 | |
| 0.009 | 0.548 | 0.054 | Sphingosine 1-phosphate receptor 5 agonist | 0.054 0.036 DBMET03366 | DBMET03366 | |
| 0.044 | 0.728 | 0.181 | Catenin beta inhibitor | 0.181 0.051 DBMET03366 | DBMET03366 | |
| 0.024 | 0.877 | 0.105 | Folate antagonist | 0.105 0.056 DBMET03366 | DBMET03366 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |